These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8388826

  • 21. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA.
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [Abstract] [Full Text] [Related]

  • 22. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969 Jan; 40(6):925-45. PubMed ID: 4310724
    [No Abstract] [Full Text] [Related]

  • 23. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F, Guillot S, Szendröi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R.
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [Abstract] [Full Text] [Related]

  • 24. Diplovax. A new oral polio vaccine.
    Med Lett Drugs Ther; 1972 Aug 04; 14(16):57-8. PubMed ID: 4346222
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Viral sequences required for neurovirulence of poliovirus.
    Racaniello VR.
    Bioessays; 1986 Dec 04; 5(6):266-70. PubMed ID: 3032167
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M, Lottenbach K, Belshe R, Rennels M, Plotkin S, Chumakov K.
    J Infect Dis; 2006 May 15; 193(10):1344-9. PubMed ID: 16619180
    [Abstract] [Full Text] [Related]

  • 33. Infectious diseases. Polio outbreak raises questions about vaccine.
    Greensfelder L.
    Science; 2000 Dec 08; 290(5498):1867-9. PubMed ID: 11187033
    [No Abstract] [Full Text] [Related]

  • 34. What threat from persistent vaccine-related poliovirus?
    MacLennan C, MacLennan J.
    Lancet; 2000 Dec 08; 366(9483):351-3. PubMed ID: 16054925
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D, Bonin O, Unterharnscheidt F, Schmidt K, Schmidt I.
    Arch Psychiatr Nervenkr (1970); 1966 Dec 08; 208(5):433-46. PubMed ID: 4291066
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D, Bonin O, Unterharnscheidt F, Schmidt K, Schmidt I.
    Arch Psychiatr Nervenkr (1970); 1966 Dec 08; 208(5):433-46. PubMed ID: 4291332
    [No Abstract] [Full Text] [Related]

  • 39. Inactivated vaccines based on alternatives to wild-type seed virus.
    Chumakov K, Dragunsky E, Ivshina A, Enterline J, Wells V, Nomura T, Gromeier M, Wimmer E.
    Dev Biol (Basel); 2001 Dec 08; 105():171-7. PubMed ID: 11763325
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.